Large American pharmaceutical companies are showing a distinct trend never seen before: they are increasingly looking for ...

Eli Lilly Chief Scientific Officer Dan Skovronsky spoke to CNBC about obesity pills and more on the future of weight loss.

Take Amgen's experimental drug MariTide: people lost up to 20% of their body weight in a Phase 2 study and Amgen shares fell about 5% on the day the results were released in November. Why?

The world’s population is aging at an unprecedented pace. According to WHO’s October 2024 report, the number of people aged 60 and older surpassed children under five for the first time in 2020. By ...

We recently published a list of the 10 Best Drug Stocks to Buy Now. In this article, we are going to take a look at where Amgen Inc. (NASDAQ:AMGN) stands against other best drug stocks to buy now.

We recently published a list of the 10 Best Drug Stocks to Buy Now. In this article, we are going to take a look at where Amgen Inc. (NASDAQ:AMGN) stands against other best drug stocks to buy now.

Revenue: US$33.4b (up 19% from FY 2023). Net income: US$4.09b (down 39% from FY 2023). Profit margin: 12% (down from 24% in FY 2023). EPS: US$7.62 (down from US$12.56 in FY 2023). Revenue was in ...

Amgen today is the biggest biotechnology company in the world, but its plush headquarters, global reach and tens of thousands of employees belie its humble origins. Founded in 1980 as Applied ...

The long-running legal dispute between Amgen and Sanofi/Regeneron on two key patents covering the use of PCSK9 inhibitors to lower cholesterol has come to an end, with Sanofi emerging as the victor.